Impact of a Communication Toolkit on Antibiotic Prescribed by General Practitioners: a Randomised Trial
NCT ID: NCT04562571
Last Updated: 2020-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
349 participants
INTERVENTIONAL
2018-10-01
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing Interventions Designed to Improve How Members of the General Public Follow Instructions to Take Antibiotics
NCT07111754
Impact on Antibiotic Prescriptions of a Bundle Intervention Conducted by Medical Representatives in General Practitioner Facilities, Based on Operational Demonstration of an Internet Decision Support Tool: Antibioclic
NCT04028830
Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse
NCT03037112
Testing New Ways to Name Antimicrobial Resistance
NCT06356285
Impact of Four Patient Information Leaflets (PIL) on Patient Behaviour
NCT01398696
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In France, outpatient antibiotic use remains above the European average. Ninety percent of antibiotics are prescribed to outpatients and 70% of these are prescribed by general practitioners.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Charter & patient information leaflets
A public commitment charter promoting antibiotic stewardship, signed by the general practitioner (GP) and displayed in the practice waiting room; a non-prescription pad, to be distributed to patients when an antibiotic is not needed; and a patient information leaflet to be used when antibiotics were prescribed
Charter & patient information leaflets
Public commitment charter, non-prescription pad, information leaflet in case of antibiotic prescription
Control
No intervention, eligible general practitioners randomised in the control group not informed of the intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Charter & patient information leaflets
Public commitment charter, non-prescription pad, information leaflet in case of antibiotic prescription
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* prescribing more than 25 antibiotic items per 100 patients without a chronic illness, aged 16 to 65 years
* proportion of patients treated with critical antibiotics exceeding 27% (among patients treated with antibiotics)
Exclusion Criteria
* GPs reaching the retirement age in the two years following the beginning of the intervention or who were not working two years before
* GPs who had already displayed a commitment charter promoting antibiotic stewardship in their practice
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lorraine
OTHER
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Céline Pulcini
Role: PRINCIPAL_INVESTIGATOR
CHRU Nancy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Université de Lorraine
Nancy, Grand Est, France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Essilini A, Le Dref G, Bocquier A, Kivits J, Welter A, Pulcini C, Thilly N; AntibioCharte scientific committee. French general practitioners' and patients' acceptability of a public commitment charter and patient information leaflets targeting unnecessary antibiotic use: a qualitative study. Antimicrob Resist Infect Control. 2022 Feb 8;11(1):32. doi: 10.1186/s13756-022-01065-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201701939
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.